Polly D.

Polly D. is a seasoned professional in clinical operations with extensive experience in cell therapy and oncology. Currently serving as the Global Study Director for Cell Therapy Clinical Operations at AstraZeneca since August 2025, Polly previously held key roles at Iovance Biotherapeutics, Inc. as Associate Director of Clinical Operations and Global Study Lead, focusing on oncology cell therapies. Prior roles include Clinical Program Manager and Senior Clinical Trial Manager at Gilead Sciences, specializing in virology and infectious disease, as well as Clinical Research Manager positions at Stanford University and Columbia University Medical Center, concentrated on radiation oncology and metabolic endocrinology respectively. Polly's earlier experience includes serving as an HIV educator with the Peace Corps in rural Swaziland and working as a Behavioral Tutor. Educational qualifications include a Master's degree in Public Health with a focus on Epidemiology from Columbia University Mailman School of Public Health and a Bachelor of Science in Biochemistry from UC San Diego.